Daiwa Securities Group
TEVA icon

Daiwa Securities Group’s Teva Pharmaceuticals TEVA Stock Holding History

Daiwa Securities Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-757
Closed -$105K – 1016
2017
Q1 		$105K Buy
+757
New +$25.8K ﹤0.01% 888
2016
Q4 		– Sell
-500
Closed -$53K – 1054
2016
Q3 		$53K Buy
+500
New +$26.1K ﹤0.01% 873

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Daiwa Securities Group's TEVA Position: Q1 2026 in Review

Daiwa Securities Group increased its Teva Pharmaceuticals (TEVA) stake by 5.1% in Q1 2026, buying an estimated $164K and bringing the position to 105,965 shares worth $3.19M. The position accounts for 0.01% of the portfolio, ranked #571.

Daiwa Securities Group first reported a position in TEVA in Q2 2016 and has held it in 40 quarters since. The position peaked at $3.24M in Q4 2016. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Daiwa Securities Group held 105,965 shares of Teva Pharmaceuticals worth $3.19M as of Q1 2026.
  • Daiwa Securities Group bought 5,100 Teva Pharmaceuticals shares in Q1 2026, an estimated $164K.
  • Teva Pharmaceuticals made up 0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #571 holding.
  • Daiwa Securities Group first reported a position in Teva Pharmaceuticals in Q2 2016 and has held it in 40 quarters since.
  • Daiwa Securities Group's Teva Pharmaceuticals position peaked at $3.24M in Q4 2016.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.